maintain hold follow result mark solid volum
natx on-going buy-back activ strong cash flow addit
dmg sale remain underway compani decid outsourc
hand function improv profit issu
bear watch ca/potenti oh ballot initi cash flow look strong
intern track remain posit dialysi fundament
continu view risk/reward balanc maintain hold rate
solid kidney result normal natx growth
touch shi adjust revenu per treatment increas
sequenti net revenu came estim
lower cost/tx drove better expect adjust oper margin
adjust ebit came ahead estim tie solid
underli trend larger benefit equiti incom on-going impact
calcimimet shift part part drove increas rev/
tx cost/tx expect expect net impact mid-singl
digit margin indirect cost drug administr
updat dmg chang dmg sale make headway
compani continu expect close addit manag
announc contract chang meaning movement drug gener
creat profit challeng compani decid
outsourc custom servic fulfil function
help allevi expect profit drag renal medic
manag roll kidney
strong flow free cash flow continu oper
adn came well ahead
addit compani repurchas stock
addit bought back sinc quarter end juli board also
approv addit repurchas program addit
outstand time bring total remain author
reiter full year capital-expenditure guidanc expect capital-expenditure
return normal level
oi cffo includ higher
tr target
tax rate reflect non-deduct increas advocaci cost around
ca potenti oh ballot initi oi estim unchang tweak
estim
result busi post adjust oper incom
includ fx gain asia-pacif jv addit manag reiter
expect gener break even oi end ex fx impact continu see
busi area opportun vehicl diversifi compani time
page
revenu
revenu
revenu
revenu
revenu
amort net tax
page
base denver co davita healthcar partner inc lead provid dialysi servic
unit state patient suffer chronic kidney failur end stage renal diseas esrd
compani enter agreement sell davita medic group optum
transact expect close
continu like core dialysi busi acknowledg potenti opportun tie
integr care longer term think dmg segment higher oper variabl increas
risk suggest lower multipl profit stream continu concern relat
premium assist remain upbeat potenti long-term opportun improv
trend dmg remain key
valuat risk
price target base trade adjust ebitda-nci discount
industri peer freseniu medic view appropri given less product geograph
diversif risk price target upsid includ better expect reimburs
oper perform downsid risk includ wors expect reimburs pressur
slow organ trend
david macdonald herebi certifi view express research report accur reflect
person view subject compani secur also certifi
receiv direct indirect compens exchang express
specif recommend report
